| Year |
Citation |
Score |
| 2006 |
Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH. Tissue expression of PD-L1 mediates peripheral T cell tolerance. The Journal of Experimental Medicine. 203: 883-95. PMID 16606670 DOI: 10.1084/Jem.20051776 |
0.594 |
|
| 2006 |
Liang SC, Greenwald RJ, Latchman YE, Rosas L, Satoskar A, Freeman GJ, Sharpe AH. PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis. European Journal of Immunology. 36: 58-64. PMID 16358363 DOI: 10.1002/Eji.200535458 |
0.577 |
|
| 2004 |
Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, Klemm M, Kuchroo VK, Freeman GJ, Sharpe AH. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proceedings of the National Academy of Sciences of the United States of America. 101: 10691-6. PMID 15249675 DOI: 10.1073/Pnas.0307252101 |
0.583 |
|
| 2003 |
Rodig N, Ryan T, Allen JA, Pang H, Grabie N, Chernova T, Greenfield EA, Liang SC, Sharpe AH, Lichtman AH, Freeman GJ. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. European Journal of Immunology. 33: 3117-26. PMID 14579280 DOI: 10.1002/Eji.200324270 |
0.565 |
|
| 2003 |
Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, Freeman GJ, Sharpe AH. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. European Journal of Immunology. 33: 2706-16. PMID 14515254 DOI: 10.1002/Eji.200324228 |
0.584 |
|
| Show low-probability matches. |